Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q4 2025 value amounting to -$3.2 million.

  • Prestige Consumer Healthcare's Change in Inventory fell 395.33% to -$3.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year increase of 957.6%. This contributed to the annual value of $9.3 million for FY2025, which is 13811.12% up from last year.
  • As of Q4 2025, Prestige Consumer Healthcare's Change in Inventory stood at -$3.2 million, which was down 395.33% from $5.8 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Change in Inventory high stood at $16.8 million for Q4 2022, and its period low was -$13.6 million during Q4 2023.
  • Its 5-year average for Change in Inventory is $1.6 million, with a median of $875500.0 in 2021.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Change in Inventory crashed by 1830000.0% in 2021, and later skyrocketed by 110340.91% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Change in Inventory (Quarter) stood at -$1.7 million in 2021, then skyrocketed by 1103.41% to $16.8 million in 2022, then crashed by 180.87% to -$13.6 million in 2023, then surged by 77.25% to -$3.1 million in 2024, then decreased by 3.95% to -$3.2 million in 2025.
  • Its Change in Inventory stands at -$3.2 million for Q4 2025, versus $5.8 million for Q3 2025 and $4.4 million for Q2 2025.